News Square
Global Crypto News · Real-time Aggregation
📚 Deep Analysis
More →GRVT Burns 1.1 Million Tokens as Countdown to Grvt 2.0 Begins
<strong>[PRESS RELEASE – Singapore, Singapore, October 20th, 2026]</strong> <strong>The discretionary buyback represents close to 1% of circulating supply and precedes four planned product milestones culminating in Grvt 2.0.</strong> <a href="https://grvt.io/" rel="nofollow noopener" target="_blank">>Grvt</a>, a self-custodial trading platform built on its own zero-knowledge (ZK) chain, announced that the Foundation’s token issuer has completed its first GRVT token buyback, purchasing and burning 1.1 million GRVT tokens on the open market. The transaction permanently removed close to 1% of GRVT’s circulating supply at the time of purchase. It marks the first of five milestones ahead of the planned launch of Grvt 2.0 at the end of November 2026. <strong>A Discretionary Buyback with On-Chain Verification</strong> The Foundation’s token issuer intends to conduct further buybacks on a monthly basis. Each transaction remains entirely at the issuer’s discretion, with no predetermined purchase amount or guaranteed schedule. Buybacks are executed through an independent execution partner, with purchased tokens transferred to a designated burn address and permanently removed from circulation. The transactions can be independently verified through the <a href="https://grvt.io/exchange/buybacks" rel="nofollow noopener" target="_blank">>public buyback dashboard</a>, which records the number of tokens purchased and burned, the percentage of circulating supply represented, cumulative burns and on-chain transaction hashes. “The GRVT token is an important part of the ecosystem we are building,” said <strong>Hong, co-founder and CEO of Grvt</strong>. “We welcome the issuer’s buybacks as a demonstration of its long-term commitment to the ecosystem and community. Grvt is expanding its products and markets, and the issuer’s buybacks sit alongside that as a supportive mechanism aimed at reducing circulating token supply.” <strong>Grvt Outlines Four Product Milestones</strong> The announcement follows GRVT’s token generation event in July 2026 and precedes a series of planned launches. <strong>Grvt Earn, scheduled for the End of October,</strong> will introduce yield opportunities backed by tokenized assets, with target yields of up to 11%. Potential returns are expected to derive from underlying asset cash flows, including interest, premiums and invoice-related income. Asset-supplying partners will be announced at launch. Target yields are not guaranteed. <strong>Stable Funding Perps, scheduled for November,</strong> will introduce perpetual futures linked to commodities, stocks, foreign exchange and indices. The contracts are planned to carry zero trading fees and use once-daily funding. Grvt aims to list more than 1,000 markets by the end of December 2026. <strong>Yield as Margin, also scheduled for November,</strong> will allow eligible Grvt Earn balances to support trading positions while continuing to accrue yield, subject to applicable product terms
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
OpenAI has bought Orchestra Bio, a San Francisco startup whose AI agents help drug companies keep sprawling development programs on schedule, the ChatGPT maker <a href="https://openai.com/index/openai-to-acquire-orchestra-bio/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>announced Tuesday</a>. “Our goal is to help scientists make discoveries and manage the work needed to turn them into treatments that reach patients sooner,” OpenAI said in the announcement. Orchestra’s team and platform will be folded into <a href="https://openai.com/rosalind/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>Rosalind</a>, OpenAI’s family of AI models and tools for biologists and chemists. The financial terms were not disclosed. Getting a new medicine from first idea to U.S. approval takes time—up to 15 years according to OpenAI. Every month shaved off that timeline is a month earlier that a new treatment can reach the people waiting for it, and a month earlier that the company can generate cash. The process is also absurdly expensive: bringing one approved drug to market can cost more than <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668846/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>$2.6 billion</a>, and <a href="https://arxiv.org/pdf/2106.05386" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">fewer than 10%</a> of candidates that enter human testing ever make it to pharmacy shelves. Beyond the science itself, OpenAI says drug teams have to coordinate work across internal departments and outside partners, often relying on systems that don’t talk to each other. Those partners usually include contract research organizations, the outside labs hired to run studies, and contract manufacturers that produce the experimental drug. Orchestra’s AI agents—software that can watch over tasks and flag problems on its own—work out which activities and deadlines take the hit, gather the relevant information and compare ways to respond, while scientists and program leaders make the final call. Founded in the fall of 2022, Orchestra raised its <a href="https://jobs.8vc.com/companies/orchestra/jobs/28818089-senior-software-engineer" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>seed round</a> from Andreessen Horowitz, Definition Capital, Insight Partners, and 8VC, and about $20 million in total, according to <a href="https://www.caplight.com/company/orchestra-bio" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">Caplight data</a>. The company should not be confused with Orchestra BioMed, an unrelated Nasdaq-listed medical device maker that trades under the ticker OBIO. In April, OpenAI launched <a href="https://decrypt.co/364783/openai-gpt-rosalind-drug-discovery-life-sciences-model" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">GPT-Rosalind</a>, a model built specifically for biology and dru
Arkham: Bybit wallet holds $15 billion
According to CoinWorld data: Arkham reports that Bybit's wallets hold approximately $15 billion, with Arkham-tagged Bybit on-chain wallets, exchange reserves, and user deposit addresses totaling about $15.25 billion. Users can track its holdings, exchange reserves, and fund flows on Arkham.
Humans&, valued at $4.5 billion, launches a collaboration model: first create "virtual humans," then teach AI to work in teams.
Coin World news: humans& has recently launched a new collaboration model aimed at first creating "virtual humans" and then teaching AI to work in teams. The company, founded only about 3 months ago, has already raised a $480 million seed round at a valuation of $4.5 billion. The founding team includes researchers who participated in the development of Claude and Grok, as well as Georges Harik, Google's 7th employee. In September, humans& released the user simulation model Persimmon, and on October 20 launched the collaboration model Ampersand trained on Zhipu GLM 5.3. In collaborative programming tests, Ampersand's collaboration success rate increased to 39% after training, 2.25 times that of the original version. The model is currently available via API, and humans& is also developing its own multiplayer collaboration product.
PeckShield：地址exploiter 1已存入约1.88万枚ETH，价值约4600万美元
According to a CoinWorld report, PeckShield has reported that the address labeled exploiter 1 has deposited a new batch of stolen funds, having sent approximately 18,800 ETH so far, worth about $46 million at current prices.
Bitget Wallet deeply integrates with PopDEX, jointly launching on-chain perpetual trading and user incentive campaigns.
Bitget Wallet has announced a deep integration with the decentralized perpetual contract trading platform PopDEX. Users can now directly connect accounts, deposit assets, and trade on-chain perpetual contracts through the in-wallet trading portal, lowering the barrier to entry. To support this integration, Bitget Wallet and PopDEX will launch a joint user campaign, allowing users trading on PopDEX to participate in cash rewards and the Megapop mechanism for additional benefits. PopDEX fully opened on October 19, launching Megapop, a weekly uncapped on-chain rolling prize pool for real traders. The platform focuses on low net trading costs, a CLOB order book, and transparent on-chain trading. This integration will expand Bitget Wallet's on-chain trading and derivatives services, providing users with an all-in-one portal that connects more real traders and professional trading communities.
Kyodo News: Sources say the Bank of Japan will decide at next week's policy meeting that it remains to be verified whether the current inflation rate has reached the 2% target level.
According to Kyodo News of Japan: sources have revealed that the Bank of Japan will decide at next week's policy meeting whether the current inflation rate has reached the 2% target level.
Hyperliquid bought back and burned 21,790 HYPE tokens in the past 24 hours.
CoinWorld data: According to onchain lens monitoring, Hyperliquid repurchased and burned 21,790 HYPE at an average price of $80.27 over the past 24 hours, equivalent to approximately $1.75 million, with estimated 24-hour fees of $1.65 million. The cumulative burn volume has reached 49.69 million HYPE (approximately $4.05 billion), accounting for 4.97% of the maximum supply of 1 billion.
Ethereum ETFs saw net outflows of $1.08 billion in October, and the ETH price fell 9.7%.
According to data from Bijie.com, net outflows from U.S. spot Ethereum ETFs in October have reached $1.08 billion, making it the largest monthly outflow in 2026. Meanwhile, the price of Ethereum fell 9.7% in October, dropping from $2,700 to $2,438. Despite this, Bitcoin ETFs recorded net inflows of $23 million during the same period, with year-to-date net inflows of approximately $809 million.
Middle East tensions push up airfare prices, Japan's September visitor arrivals fall 5% year-on-year.
According to data released by the Japan National Tourism Organization (JNTO) on the 21st, the number of visitors to Japan in September was 3.1037 million, a decrease of 5.0% compared with the same period last year, marking the second consecutive month of decline. The worsening situation in the Middle East has pushed up fuel prices, leading to higher airfare and affecting the number of visitors to Japan. The number of tourists from Europe decreased. The number of visitors from Germany in September was 46,100, a year-on-year decrease of 12.7%; visitors from the United Kingdom were 45,200, down 4.1% year on year; and visitors from France were 35,700, down 8.0% year on year.